课题基金 / 基金详情

NORNICOTINE CONTRIBUTION TO THE CNS EFFECT OF NICOTINE

NORNICOTINE CONTRIBUTION TO THE CNS EFFECT OF NICOTINE
去甲尼古丁对尼古丁中枢神经系统作用的贡献
批准号:
2872061
负责人:
Linda P Dwoskin
金额:
$12.24万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-04-10 至 2001-01-31

项目摘要

项目成果

Linda P Dwoskin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Applicant's Abstract) Cigarette smoking is the number one health problem accounting for more illnesses and deaths than any other single factor. The abuse liability of the major tobacco alkaloid, nicotine (NIC), stems from its intrinsic reinforcing properties suggested to be the result of activation of dopamine (DA) pathways in brain. Elucidation of NIC's mechanism of action and determination of the effects of chronic administration are important for understanding the initiation/maintenance of smoking behavior, and for overcoming problems that smokers experience in extinguishing this behavior. Considering the plethora of information on the peripheral metabolism of NIC, little is known about NIC metabolism in brain and about the potential pharmacologic activity of NIC metabolites. The overall objective of this proposal is to test the hypothesis that CNS effects resulting from NIC exposure during tobacco usage are not solely due to NIC, but result at least in part from actions of NIC metabolites. We have recently demonstrated that NIC metabolites (cotinine, nornicotine (norNIC), norcotinine, and an as yet unidentified fourth metabolite) are present in brain 4 hours after acute peripheral [2'-14C]NIC administration. Also, we have found that norNIC increases DA release from superfused rat striatal slices in a concentration-dependent, Ca++ -dependent, mecamylamine-sensitive, dihydro-beta-erythroidine-sensitive, and stereo-selective manner, indicating nicotinic receptor mediation. Also similar to NIC, repeated S(-) or R(+)norNIC administration were capable of activating the neural mechanism(s) responsible for behavioral sensitization, even though R(+)norNIC produced no overt behavioral effects after its repeated administration. The proposed project will determine the kinetics of accumulation of NIC metabolites in brain, the pharmacological activity and mechanism of action of NIC metabolites, and the time-dependent behavioral and neurochemical changes in response to repeated norNIC administration. The results of the proposed studies will increase our knowledge of the molecular mechanisms that are involved in the neurobehavioral effects resulting from tobacco use and NIC exposure.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
Plasma cotinine, 3'-hydroxycotinine, and their glucuronides in white and black smokers.
白人和黑人吸烟者的血浆可替宁、3-羟基可替宁及其葡萄糖苷酸。
DOI: 10.1097/00004714-200304000-00018
发表时间: 2003
期刊: Journal of clinical psychopharmacology
影响因子: 2.9
作者: [deLeon,Jose, Diaz,FranciscoJ, Rogers,Thea, Browne,Debra, Dinsmore,Lori, Ghosheh,OmarA, Dwoskin,LindaP, Crooks,PeterA]
通讯作者: Crooks,PeterA
DOI: --
发表时间: 1999-12
期刊: Drug metabolism and disposition: the biological fate of chemicals
影响因子: --
作者: [Omar A. Ghosheh;L. Dwoskin;Wen-kui Li;P. Crooks]
通讯作者: Omar A. Ghosheh;L. Dwoskin;Wen-kui Li;P. Crooks
Locomotor stimulant effects of nornicotine: role of dopamine.
去甲尼古丁的运动兴奋作用:多巴胺的作用。
DOI: 10.1016/s0091-3057(02)00960-7
发表时间: 2002
期刊: Pharmacology, biochemistry, and behavior
影响因子: --
作者: [Green,TA, Brown,RW, Phillips,SB, Dwoskin,LP, Bardo,MT]
通讯作者: Bardo,MT
Nicotinic-receptor mediation of S(-)nornicotine-evoked -3H-overflow from rat striatal slices preloaded with -3H-dopamine.
S(-)降烟碱的烟碱受体介导从预载有-3H-多巴胺的大鼠纹状体切片中诱发-3H-溢出。
DOI: --
发表时间: 1997
期刊: The Journal of pharmacology and experimental therapeutics.
影响因子: --
作者: [Teng,L, Crooks,PA, Buxton,ST, Dwoskin,LP]
通讯作者: Dwoskin,LP
6
    Kentucky Network for Innovation & Commercialization (“KYNETIC”)
    • 批准号:
      10475211
    • 项目类别:
    • 资助金额:
      $95.82万
    • 财政年份:
      2019
    • 负责人:
      Linda P Dwoskin
    • 依托单位:
    Development of Novel Therapeutics for Methamphetamine Abuse
    • 批准号:
      10186610
    • 项目类别:
    • 资助金额:
      $10.0万
    • 财政年份:
      2018
    • 负责人:
      Linda P Dwoskin
    • 依托单位:
    Development of Novel Therapeutics for Methamphetamine Abuse
    • 批准号:
      9750673
    • 项目类别:
    • 资助金额:
      $83.92万
    • 财政年份:
      2018
    • 负责人:
      Linda P Dwoskin
    • 依托单位:
    Development of Antagonists for M5 Muscarinic Acetylcholine Receptor
    • 批准号:
      7768413
    • 项目类别:
    • 资助金额:
      $18.13万
    • 财政年份:
      2009
    • 负责人:
      Linda P Dwoskin
    • 依托单位:
    海外基金